These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 28885915)
1. Nanosized Liposomes Containing Bile Salt: A Vesicular Nanocarrier for Enhancing Oral Bioavailability of BCS Class III Drug. Arafat M; Kirchhoefer C; Mikov M; Sarfraz M; Löbenberg R J Pharm Pharm Sci; 2017; 20(0):305-318. PubMed ID: 28885915 [TBL] [Abstract][Full Text] [Related]
2. Mixed Micelles Loaded with Bile Salt: An Approach to Enhance Intestinal Transport of the BCS Class III Drug Cefotaxime in Rats. Arafat M; Kirchhoefer C; Mikov M Eur J Drug Metab Pharmacokinet; 2017 Aug; 42(4):635-645. PubMed ID: 27686853 [TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose. Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880 [TBL] [Abstract][Full Text] [Related]
4. Bile salt liposomes for enhanced lymphatic transport and oral bioavailability of paclitaxel. Zhang B; Xue A; Zhang C; Yu J; Chen W; Sun D Pharmazie; 2016 Jun; 71(6):320-6. PubMed ID: 27455550 [TBL] [Abstract][Full Text] [Related]
5. Denatured globular protein and bile salt-coated nanoparticles for poorly water-soluble drugs: Penetration across the intestinal epithelial barrier into the circulation system and enhanced oral bioavailability. He W; Yang K; Fan L; Lv Y; Jin Z; Zhu S; Qin C; Wang Y; Yin L Int J Pharm; 2015 Nov; 495(1):9-18. PubMed ID: 26325310 [TBL] [Abstract][Full Text] [Related]
6. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt. Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416 [TBL] [Abstract][Full Text] [Related]
7. Bile salt integrated cerasomes: A potential nanocarrier for enhancement of the oral bioavailability of idarubicin hydrochloride. Emzhik M; Haeri A; Javidi J; Abdollahizad E; Qaribnejad A; Rezaee E; Torshabi M; Dadashzadeh S Int J Pharm; 2024 Sep; 662():124518. PubMed ID: 39074645 [TBL] [Abstract][Full Text] [Related]
8. Niosomal carriers enhance oral bioavailability of carvedilol: effects of bile salt-enriched vesicles and carrier surface charge. Arzani G; Haeri A; Daeihamed M; Bakhtiari-Kaboutaraki H; Dadashzadeh S Int J Nanomedicine; 2015; 10():4797-813. PubMed ID: 26251598 [TBL] [Abstract][Full Text] [Related]
9. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Guan P; Lu Y; Qi J; Niu M; Lian R; Hu F; Wu W Int J Nanomedicine; 2011; 6():965-74. PubMed ID: 21720508 [TBL] [Abstract][Full Text] [Related]
10. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media. Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580 [TBL] [Abstract][Full Text] [Related]
11. Bile salt/phospholipid mixed micelle precursor pellets prepared by fluid-bed coating. Dong F; Xie Y; Qi J; Hu F; Lu Y; Li S; Wu W Int J Nanomedicine; 2013; 8():1653-63. PubMed ID: 23641154 [TBL] [Abstract][Full Text] [Related]
12. Pueraria flavones-loaded bile salt liposomes with improved intestinal absorption and oral bioavailability: Tang M; Gui Z; Liang X; Yan C; Li X; Li Z; He N; Chang X; Guo J; Gui S Pharm Dev Technol; 2021 Dec; 26(10):1051-1060. PubMed ID: 34511044 [TBL] [Abstract][Full Text] [Related]
13. Liposomes incorporating sodium deoxycholate for hexamethylmelamine (HMM) oral delivery: development, characterization, and in vivo evaluation. Sun J; Deng Y; Wang S; Cao J; Gao X; Dong X Drug Deliv; 2010 Apr; 17(3):164-70. PubMed ID: 20196698 [TBL] [Abstract][Full Text] [Related]
14. Enhanced oral bioavailability of silymarin using liposomes containing a bile salt: preparation by supercritical fluid technology and evaluation in vitro and in vivo. Yang G; Zhao Y; Zhang Y; Dang B; Liu Y; Feng N Int J Nanomedicine; 2015; 10():6633-44. PubMed ID: 26543366 [TBL] [Abstract][Full Text] [Related]
15. Effects of bile salts on the lovastatin pharmacokinetics following oral administration to rats. Kim K; Yoon I; Chun I; Lee N; Kim T; Gwak HS Drug Deliv; 2011 Jan; 18(1):79-83. PubMed ID: 20809680 [TBL] [Abstract][Full Text] [Related]
16. The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles. van Hasselt PM; Janssens GE; Slot TK; van der Ham M; Minderhoud TC; Talelli M; Akkermans LM; Rijcken CJ; van Nostrum CF J Control Release; 2009 Jan; 133(2):161-8. PubMed ID: 18955093 [TBL] [Abstract][Full Text] [Related]
17. Characteristics and behaviour of liposomes when incubated with natural bile salt extract: implications for their use as oral drug delivery systems. Hermida LG; Sabés-Xamaní M; Barnadas-Rodríguez R Soft Matter; 2014 Sep; 10(35):6677-85. PubMed ID: 25060405 [TBL] [Abstract][Full Text] [Related]
18. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery. Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774 [TBL] [Abstract][Full Text] [Related]
20. In situ and in vivo efficacy of peroral absorption enhancers in rats and correlation to in vitro mechanistic studies. Sharma P; Varma MV; Chawla HP; Panchagnula R Farmaco; 2005; 60(11-12):874-83. PubMed ID: 16243320 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]